|
|
Volumn 122, Issue 9, 2010, Pages
|
|
Letter by smolderen and pelle regarding article, efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: A randomized trial
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
VARENICLINE;
BENZAZEPINE DERIVATIVE;
NICOTINIC AGENT;
QUINOXALINE DERIVATIVE;
CARDIOVASCULAR DISEASE;
CIGARETTE SMOKING;
CLINICAL PRACTICE;
CLINICAL TRIAL;
COMORBIDITY;
DEPRESSION;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
LETTER;
MEDICAL SOCIETY;
PREVALENCE;
PRIORITY JOURNAL;
SMOKING CESSATION;
TOBACCO DEPENDENCE;
CARDIOVASCULAR DISEASES;
PATIENT SELECTION;
PROCEDURES;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RISK FACTOR;
SMOKING;
BENZAZEPINES;
CARDIOVASCULAR DISEASES;
DEPRESSION;
HUMANS;
NICOTINIC AGONISTS;
PATIENT SELECTION;
QUINOXALINES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK FACTORS;
SMOKING;
SMOKING CESSATION;
|
|
EID: 77956386370
PISSN: 00097322
EISSN: 15244539
Source Type: Journal
DOI: 10.1161/CIRCULATIONAHA.110.942086 Document Type: Letter |
|
Times cited : (5)
|
|
References (5)
|
